Magnolia Medical Technologies develops innovative medical products that achieve predictable, high-quality outcomes. The company's first product SteriPath is the only clinically proven blood culture collection solution that maintains consistent, sustainable contamination rates as low as 0.2%. By enabling providers to consistently execute best practices, SteriPath virtually eliminates false positives--mitigating previously unavoidable clinical and financial risks, reducing unnecessary treatment, and ensuring optimal patient outcomes.